Developing potent anti-inflammatory IRAK4-targeting PROTACs with simplified CRBN ligands

Yu Rao(Soochow University), Peilu Song(Tsinghua University), Yujie Liu(Shanxi University of Traditional Chinese Medicine), Xiuyun Sun(Tsinghua University), Xin Zhai(Shenyang Pharmaceutical University)
Chinese Chemical Letters
March 4, 2025
10.1016/j.cclet.2025.111033
Cited by 2

Related Papers

PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
|Nature|2012|488
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270